A new CDC campaign "Free Mind" addresses rising drug overdoses and mental health issues among youth, offering vital resources ...

Results from the Phase III NEPTUNUS-1 (NCT05350072) and NEPTUNUS-2 (NCT05349214) trials demonstrated that ianalumab ...

The journal is standing by the study, which looked into the safety of vaccines that have aluminum ingredients.

Accelerated approval was based on results from the Phase Ib Beamion-LUNG 1 trial (NCT04886804), which showed a 75% objective ...

Today, imaging often exists independently of molecular insights, trial data, treatment decisions, and longitudinal patient ...

Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and ...

GLP-1 medication users must consult physicians before surgery to mitigate anesthesia risks and ensure safe pre-operative ...

In May, Pfizer CEO Dr. Albert Bourla defended previous comments HHS officials made about mRNA vaccines. 2 At the time, he called mRNA vaccines the most utilized vaccines in human history. He cited the ...

Access inequity is driven by operational and bureaucratic challenges, affecting both low-income and developed nations, beyond ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

Chai Discovery secures $70 million to revolutionize AI-driven drug discovery, enhancing antibody design and accelerating ...